Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Alaunos Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 1.47 · gapped above the open, then crossed back over prior close. High/low 1.49 at 12:00 pm ET, 1.41 at 7:45 pm ET.
29 institutional managers report a position in Alaunos Therapeutics, Inc. worth $204,421 between them, filed on form 13F for the quarter ending 2026-06-30. 5 of them hold 80% of it, the largest being BlackRock, Inc. at 23.61%.
4 more managers in the register
5 managers hold 80% of the $204,421 institutional base. The other 24 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
No concentrated manager holds a large enough stake in both this company and another we cover. Its institutional base is mostly broad money, spread across most of the market, which says nothing about what else a reader might look at.
TCRT (Alaunos Therapeutics, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.